Patients reported a pleasant and pain-free experience and were satisfied with the results...I am impressed by the immediate and long-term results achieved with the TriPollar technology.
Steven Shapiro, M.D. USA
(PRWEB) January 09, 2012
Pollogen Ltd., a leader in medical aesthetics announced today that it has received FDA clearance to market the Apollo system powered by TriPollar technology in the US. The Apollo is a clinically proven anti-aging solution that safely and effectively treats facial wrinkles and rhytides. Results are visible after the very first treatment and long-term results are achieved by undergoing a series of treatments. Treatment is completely non-invasive, safe and pleasant and following treatment customers can resume their daily routine. Unlike other technologies, TriPollar, a 3rd generation RF technology, is color blind, allowing patients of all skin types to achieve measurable anti-aging results. With the aesthetic medical arena seeing daily proliferation of a myriad of invasive or painful treatment options, Apollo has captured a place as providing the genuinely pleasant, pain-less and effective anti-aging solution.
TriPollar technology is a 3rd generation radiofrequency solution designed and manufactured exclusively by Pollogen Ltd. TriPollar overcomes the limitations of previous mono-polar and bi-polar technologies and offers a technology with a superior safety and efficacy profile. This safety and efficacy has been proven in multiple clinical studies and published in eight peer reviewed articles. TriPollar has become an industry standard, and Apollo systems have been sold internationally, outside the USA, since 2008. There are thousands of installed systems in over 60 countries with more than a million TriPollar treatments performed to date.
“As principle investigator of Pollogen’s FDA clinical trial, I am pleased to be the first practice to work with TriPollar technology in the USA. We performed 136 treatments in our FDA study without any side effects,” stated Steven Shapiro M.D., Vol. Associate Professor in the Department of Dermatology and Cutaneous Surgery at the University of Miami School of Medicine. “Patients reported a pleasant and pain-free experience and were satisfied with the results. I observed a significant reduction in wrinkles and overall, I am impressed by the immediate and long-term results achieved with the TriPollar technology of the Apollo system and its strong safety profile.”
Pollogen’s CEO, Mr. Amichai Bar Nir stated: “We are very excited that U.S. customers can now experience TriPollar treatments. We have received exceptionally positive feedback from leading key opinion physicians in the U.S. that are anxious to start working with the Apollo system. We are confident that the Apollo will be well accepted in the U.S. as it has been in the rest of the world.”
Pollogen Ltd. is a global leader in the medical aesthetics market providing innovative, safe and effective solutions for women and men that enhance and expand the practice of medical aesthetic professionals. The company offers products to address a range of skin treatments under the industry’s three premier brands: TriPollar, TriLipo and TriFractional.
Pollogen offers a full line of clinically-proven, non-invasive anti-aging facial and body contouring treatment platforms for circumference reduction, cellulite reduction and skin tightening. The company’s medical aesthetic devices, Maximus, Apollo, and Regen XL offer customers clinically-proven, safe and effective anti-aging lunchtime beauty treatments that deliver immediate and long-lasting results. With a distribution network in over 60 countries, Pollogen is providing innovative solutions to medical professionals globally.